In vivo progestogen release from implants
Chauhan, P.S.; Varma, K.C.
Indian Journal of Pharmaceutical Sciences 48(6): 203-204
1986
ISSN/ISBN: 0250-474X Document Number: 639868
Document emailed within 1 workday
Related Documents
Civiale, C.; Ritschel, W.A.; Shiu, G.K.; Aiache, J.M.; Beyssac, E. 1991: In vivo-in vitro correlation of salbutamol release from a controlled release osmotic pump delivery system Methods and Findings in Experimental and Clinical Pharmacology 13(7): 491-498Asnake, M.; Henry, E.G.; Tilahun, Y.; Oliveras, E. 2013: Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 123 Suppl. 1: E29-E32
Asnake, M.; Henry, E.G.; Tilahun, Y.; Oliveras, E. 2013: Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 123 Suppl. 1: E29-E32
Asnake, M.; Henry, E.G.; Tilahun, Y.; Oliveras, E. 2013: Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 123 Suppl. 1: E29-E32
Gemzell-Danielsson, K.; van Heusden, A.M.; Killick, S.R.; Croxatto, H.B.; Bouchard, P.; Cameron, S.; Bygdeman, M. 2002: Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen Human Reproduction 17(10): 2588-2593
Gemzell-Danielsson, K.; van Heusden, A.M.; Killick, S.R.; Croxatto, H.B.; Bouchard, P.; Cameron, S.; Bygdeman, M. 2002: Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen Human Reproduction 17(10): 2588-2593
Chrisman, C.E.; Curtis, K.M.; Mohllajee, A.P.; Gaffield, M.E.; Peterson, H.B. 2006: Effective use of hormonal contraceptives: Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants Contraception 73(2): 125-133
Chrisman, C.E.; Curtis, K.M.; Mohllajee, A.P.; Gaffield, M.E.; Peterson, H.B. 2006: Effective use of hormonal contraceptives: Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants Contraception 73(2): 125-133
Chrisman, C.E.; Curtis, K.M.; Mohllajee, A.P.; Gaffield, M.E.; Peterson, H.B. 2006: Effective use of hormonal contraceptives: Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants Contraception 73(2): 125-133
Chrisman, C.E.; Curtis, K.M.; Mohllajee, A.P.; Gaffield, M.E.; Peterson, H.B. 2006: Effective use of hormonal contraceptives: Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants Contraception 73(2): 125-133
Shors, E.C.; Fu, P.C.; Matsumura, K.; Cohen, A.H.; Benfield, J.R. 1978: Sustained-release endobronchial carcinogenic implants Surgical Forum 29: 205-207
Richter, E.J. 1995: In vivo vertical forces on implants International Journal of Oral and Maxillofacial Implants 10(1): 99-108
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
Egarter, C. 2020: Progestogen-only pills: which progestogen would be ideal Hormone Molecular Biology and Clinical Investigation 42(2): 149-151
Marouf, H.A.; Quayle, A.A.; Sloan, P. 1990: In vitro and in vivo studies with collagen/hydroxyapatite implants International Journal of Oral and Maxillofacial Implants 5(2): 148-154
Elias-Al-Mamun, M.; Khan, H.A.; Dewan, I.; Jalil, R.-U. 2009: In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants Pakistan Journal of Pharmaceutical Sciences 22(4): 360-367